BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15555209)

  • 1. Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival.
    Ochs AM; Wong L; Kakani V; Neerukonda S; Gorske J; Rao A; Riggs M; Ward H; Keville L
    Clin Colorectal Cancer; 2004 Nov; 4(4):262-7. PubMed ID: 15555209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas.
    Li Q; Wang D; Li J; Chen P
    BMC Cancer; 2011 Jun; 11():277. PubMed ID: 21708009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
    Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; Bucana CD; O'Reilly MS; Hong WK; Fidler IJ; Putnam JB; Herbst RS
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):136-43. PubMed ID: 14734462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
    Saad RS; Liu Y; Han H; Landreneau RJ; Silverman JF
    Mod Pathol; 2004 Oct; 17(10):1235-42. PubMed ID: 15167937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and prognostic significance of VEGF, PDGF-B, and HER2/neu expression in gallbladder cancer.
    Shukla P; Mishra K; Shukla R; Vishwakarma R; Kumari N; Krishnani N; Behari A; Kapoor VK
    J Cancer Res Ther; 2024 Jan; 20(1):349-357. PubMed ID: 38554345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Human Epidermal Growth Factor Receptor (HER2/neu) in the Prognosis of Patients with Gastric Cancer.
    Aznab M; Maleksabet D; Khazaei S; Khazaei M; Rezaei M
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):1989-1994. PubMed ID: 31350955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis.
    Khorana AA; Ryan CK; Cox C; Eberly S; Sahasrabudhe DM
    Cancer; 2003 Feb; 97(4):960-8. PubMed ID: 12569594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of HER2-neu Expression in Colonic Adenocarcinoma in the West of Iran.
    Madani SH; Sadeghi E; Rezaee A; Sadeghi M; Khazaee S; Amirifard N; Payandeh M
    Asian Pac J Cancer Prev; 2015; 16(17):7671-4. PubMed ID: 26625779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer.
    Abdelrahman AE; Rashed HE; Elkady E; Elsebai EA; El-Azony A; Matar I
    Ann Diagn Pathol; 2019 Apr; 39():42-52. PubMed ID: 30684846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients.
    Konecny GE; Meng YG; Untch M; Wang HJ; Bauerfeind I; Epstein M; Stieber P; Vernes JM; Gutierrez J; Hong K; Beryt M; Hepp H; Slamon DJ; Pegram MD
    Clin Cancer Res; 2004 Mar; 10(5):1706-16. PubMed ID: 15014023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
    Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
    Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor in invasive ductal carcinoma of the breast and the relation to angiogenesis and p53 and HER-2/neu protein expression.
    Lee JS; Kim HS; Jung JJ; Kim YB; Lee MC; Park CS
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):289-95. PubMed ID: 12607595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer.
    Tokunaga T; Oshika Y; Abe Y; Ozeki Y; Sadahiro S; Kijima H; Tsuchida T; Yamazaki H; Ueyama Y; Tamaoki N; Nakamura M
    Br J Cancer; 1998 Mar; 77(6):998-1002. PubMed ID: 9528847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic breast cancer with HER2/neu-positive cells tends to have a morbid prognosis.
    Emi Y; Kitamura K; Shikada Y; Kakeji Y; Takahashi I; Tsutsui S
    Surgery; 2002 Jan; 131(1 Suppl):S217-21. PubMed ID: 11821814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
    Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray.
    Rakhshani N; Kalantari E; Bakhti H; Sohrabi MR; Mehrazma M
    Asian Pac J Cancer Prev; 2014; 15(18):7597-602. PubMed ID: 25292034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
    Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
    Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor.
    Pegram MD; Reese DM
    Semin Oncol; 2002 Jun; 29(3 Suppl 11):29-37. PubMed ID: 12138395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
    Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
    Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.